Issued Patents All Time
Showing 1–23 of 23 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12358942 | Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid | Bret Berner, John Gregory Reid, Jian Wang, James J. Doherty, Stephen Jay Kanes | 2025-07-15 |
| 11884696 | Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid | Bret Berner, John Gregory Reid, Jian Wang, James J. Doherty, Stephen Jay Kanes | 2024-01-30 |
| 11236121 | Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid | Bret Berner, John Gregory Reid, Jian Wang, James J. Doherty, Stephen Jay Kanes | 2022-02-01 |
| 8835457 | Bridged bicyclic RHO kinase inhibitor compounds, compositions and use | John W. Lampe, David J. Slade | 2014-09-16 |
| 8604218 | Cytoskeletal active rho kinase inhibitor compounds, composition and use | John W. Lampe, David J. Slade, Ward M. Peterson, Christopher S. Crean, Jason L. Vittitow +2 more | 2013-12-10 |
| 8604205 | Cytoskeletal active rho kinase inhibitor compounds, composition and use | John W. Lampe, David J. Slade, Ward M. Peterson, Christopher S. Crean, Jason L. Vittitow +2 more | 2013-12-10 |
| 8476295 | Bridged bicyclic RHO kinase inhibitor compounds, composition and use | John W. Lampe, David J. Slade | 2013-07-02 |
| 8158796 | Process for the preparation of Rho-kinase inhibitor compounds | Jin She, Jonathan Bryan DeCamp, David J. Slade | 2012-04-17 |
| 8071779 | Cytoskeletal active rho kinase inhibitor compounds, composition and use | John W. Lampe, David J. Slade, Ward M. Peterson, Christopher S. Crean, Jason L. Vittitow +2 more | 2011-12-06 |
| 8039465 | Cytoskeletal active compounds, composition and use | John W. Lampe, Robert Plourde, Jr., Jin She, Jason L. Vittitow, Michael T. Crimmins +1 more | 2011-10-18 |
| 7947850 | Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones | Jonathan Bryan DeCamp, Jin She | 2011-05-24 |
| 7943760 | Non-nucleotide composition for inhibiting platelet aggregation | Robert Plourde, Jr., Sammy R. Shaver, James G. Douglass, III, José L. Boyer, Chi Tu +5 more | 2011-05-17 |
| 7932376 | Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation | James G. Douglass, III, Sammy R. Shaver, Krzysztof Bednarski | 2011-04-26 |
| 7741473 | Process for the preparation of 4,6-disubstituted-tetrahydro-furo, thieno, pyrrolo and cyclopenta-[3,4][1,3]dioxoles | James G. Douglass, III, Bob Suchozak, Subramanian Pandiaraju, Craig Edward Dixon, Daniel Levin | 2010-06-22 |
| 7666861 | Cytoskeletal active compounds, composition and use | John W. Lampe, Robert Plourde, Jr., Jin She, Jason L. Vittitow, Michael T. Crimmins +1 more | 2010-02-23 |
| 7592445 | Non-nucleotide composition and method for inhibiting platelet aggregation | Robert Plourde, Jr., Sammy R. Shaver, James G. Douglass, III, José L. Boyer, Chi Tu +5 more | 2009-09-22 |
| 7504497 | Orally bioavailable compounds and methods for inhibiting platelet aggregation | James G. Douglass, III, Carl A. Samuelson, Christopher S. Crean | 2009-03-17 |
| 7414137 | Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones | Jonathan Bryan DeCamp, Jin She | 2008-08-19 |
| 7335648 | Non-nucleotide composition and method for inhibiting platelet aggregation | Robert Plourde, Jr., Sammy R. Shaver, James G. Douglass, III, José L. Boyer, Chi Tu +5 more | 2008-02-26 |
| 7320974 | Cytoskeletal active compounds, compositions and use | John W. Lampe, Robert Plourde, Jr., Jin She, Jason L. Vittitow, Michael T. Crimmins +1 more | 2008-01-22 |
| 6906066 | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, Dean A. Wacker +2 more | 2005-06-14 |
| 6706735 | 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity | Soo S. Ko, George V. DeLucca, John V. Duncia, Joseph B. Santella, Dean A. Wacker | 2004-03-16 |
| 6441001 | 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity | Soo S. Ko, George V. DeLucca, Joseph B. Santella, Dean A. Wacker, John V. Duncia | 2002-08-27 |